Sex, the heart, and heart failure

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 3, 2006, Pages 256-258

  Kiowski, Wolfgang ^a   Brunner, Hanspeter ^b   Schalcher, Christoph ^a  

^a KLINIK IM PARK   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Chronic heart failure; PDE 5 inhibitors; Sex

Indexed keywords

GLYCERYL TRINITRATE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CONFERENCE PAPER; DRUG CONTRAINDICATION; DRUG MECHANISM; ERECTILE DYSFUNCTION; HEART FAILURE; HEART FUNCTION; HEART WORK; HUMAN; IMPOTENCE; MALE; SEXUAL BEHAVIOR;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; 3',5'-CYCLIC-GMP PHOSPHODIESTERASES; CARDIOVASCULAR DISEASES; ERECTILE DYSFUNCTION; HEART; HUMANS; HYPOTENSION; IMPOTENCE; MALE; MYOCARDIAL INFARCTION; NITRATES; PHOSPHODIESTERASE INHIBITORS; RISK FACTORS; SEXUAL BEHAVIOR; VASODILATOR AGENTS;

EID: 33747114979     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253206291149     Document Type: Conference Paper

References (18)

1. Masters WH, Johnson VE. Human Sexual Response. Boston, MA: Little, Brown; 1966.
2. Hellerstein HK, Friedman EH. Sexual activity and the post-coronary patient. Arch Intern Med. 1970;125:987-999.
3. Bohlen JG, Held JP, Sanderson MO, Patterson RP. Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. Arch Intern Med. 1984;144:1745-1748.
4. Mann S, Craig MW, Gould BA, Melville DI, Raftery EB. Coital blood pressure in hypertensives. Cephalgia, syncope, and the effects of beta-blockade. Br Heart J. 1982;47:84-89.
5. Cantwell JD. Sex and the heart. Med Aspects Hum Sex. 1981;15:14-23.
6. Muller JE, Mittleman A, Maclure M, Sherwood JB, Tofler GH. Triggering myocardial infarction by sexual activity. Low absolute risk and prevention by regular physical exertion. Determinants of Myocardial Infarction Onset Study Investigators. JAMA. 1996;275:1405-1409.
7. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163:460-463.
8. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96:313-321.
9. Shakir SA, Wilton LV, Boshier A, Layton D, Heeley E. Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England. BMJ. 2001;322:651-652.
10. Wysowski DK, Farinas E, Swartz L. Comparison of reported and expected deaths in sildenafil (Viagra) users. Am J Cardiol. 2002;89:1331-1334.
11. Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic effects of sildenafil in men with severe coronary artery disease. N Engl J Med. 2000;342:1622-1626.
12. Arruda-Olson AM, Mahoney DW, Nehra A, Leckel M, Pellikka PA. Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial. JAMA. 2002;287:719-725.
13. Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil. Am J Cardiol. 2003;92(9A):37M-46M.
14. Katz SD, Parker JD, Glasser DB, et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure. Am J Cardiol. 2005;95:36-42.
15. Katz SD, Balidemaj K, Homma S, Wu H, Wang J, Maybaum S. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure. J Am Coll Cardiol. 2000;36:845-851.
16. Bocchi EA, Guimaraes G, Mocelin A, Bacal F, Bellotti G, Ramires JF. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation. 2002;106:1097-1103.
17. Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation. 2002;105:2398-2403.
18. Michelakis ED, Tymchak W, Noga M, et al. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation. 2003;108:2066-2069.